Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH075472B2 - External skin preparation - Google Patents
[go: Go Back, main page]

JPH075472B2 - External skin preparation - Google Patents

External skin preparation

Info

Publication number
JPH075472B2
JPH075472B2 JP61152362A JP15236286A JPH075472B2 JP H075472 B2 JPH075472 B2 JP H075472B2 JP 61152362 A JP61152362 A JP 61152362A JP 15236286 A JP15236286 A JP 15236286A JP H075472 B2 JPH075472 B2 JP H075472B2
Authority
JP
Japan
Prior art keywords
extract
skin
solution
added
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP61152362A
Other languages
Japanese (ja)
Other versions
JPS638336A (en
Inventor
幸男 坪井
義隆 宇治
裕治 柴山
勝作 川田
Original Assignee
岩瀬コスフア株式会社
山川生化学工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 岩瀬コスフア株式会社, 山川生化学工業株式会社 filed Critical 岩瀬コスフア株式会社
Priority to JP61152362A priority Critical patent/JPH075472B2/en
Publication of JPS638336A publication Critical patent/JPS638336A/en
Publication of JPH075472B2 publication Critical patent/JPH075472B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 この発明は皮膚外用剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to an external preparation for skin.

〔従来の技術〕[Conventional technology]

従来、チヨレイマイタケはその地下部菌核を猪苓とい
い、古来漢方の要薬として五苓散、猪令湯などの処方に
配合されており、その効果は利水、消腫、利湿、解熱の
作用があるとされている。その地上部の子実体(キノ
コ)はまれに初夏および秋に発生し食用に供せられ珍重
されて来た。地下部菌核の成分としてはエルゴステロー
ル(Ergosterol)、α−ヒドロキシテラコサノ酸(α−
Hydroxyter−acosanoic Acid)および多糖類などが知ら
れ特にその多糖類には抗ガン作用があるとされている。
Traditionally, Chiyorei-maitake is called the boar flesh due to its underground sclerotium, and it has been compounded in prescriptions such as Gorei-san, Ino-rei-to as an important medicine of ancient Chinese herbs. It is said to have an antipyretic effect. The fruiting bodies (mushrooms) on the above-ground part rarely occur in early summer and autumn and have been used for food and prized. Ergosterol and α-hydroxyterracanoic acid (α-
Hydroxyter-acosanoic acid) and polysaccharides are known, and in particular, the polysaccharides are said to have anti-cancer action.

チヨレイマイタケの菌体培養法は既に特開昭52−28987
号公報および特開昭52−61283号公報に開示されている
が、これらの方法では副生成物を含み、皮膚外用剤へ利
用することは決して満足出来ることではない。チヨレイ
マイタケの菌核から直接抽出物を得ようとする方法は特
開昭55−159796号公報に示されている。また、これら方
法で得られたものの効能については抗ガン作用に関する
ものが主であり、皮膚外用剤に主眼を置いたものはな
い。
The method for culturing the fungus body of Pleurotus cornucopia has already been disclosed in JP-A-52-28987.
JP-A No. 52-61283 and JP-A No. 52-61283 disclose that these methods include by-products and are not satisfactory for use as an external preparation for skin. A method for directly obtaining an extract from the sclerotia of Pleurotus cornucopiae is disclosed in JP-A-55-159796. Further, regarding the efficacy of the products obtained by these methods, those mainly related to the anti-cancer action, and none of them focus on the external preparation for skin.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

このように従来の技術においては、チヨレイマイタケの
有効成分が皮膚外用剤として充分に活用されていないと
いう問題点があつた。
As described above, the conventional technique has a problem in that the active ingredient of Chlorella edulis has not been sufficiently utilized as an external preparation for skin.

〔問題点を解決するための手段〕[Means for solving problems]

上記の問題点を解決するために、この発明はサルノコシ
カケ科チヨレイマイタケ〔Polyporus umbellatus Fries
(Polyporaceae)〕の子実体または新鮮な菌核から分離
培養した菌糸体抽出液もしくはその乾燥物を皮膚外用剤
に含有させるという手段を採用したものである。以下そ
の詳細を述べる。
In order to solve the above-mentioned problems, the present invention relates to Polyporus umbellatus Fries.
(Polyporaceae)] fruit body or a mycelium extract separated and cultivated from fresh sclerotium or a dried product thereof is contained in a skin external preparation. The details will be described below.

まず、この発明におけるチヨレイマイタケ菌の種菌は収
穫直後の子実体または菌核から寒天培地による植継を数
回繰り返えして雑菌の混入のないことが確認された菌糸
体である。
First, the inoculum of Mycobacterium tuberculosis in the present invention is a mycelium confirmed to be free from miscellaneous bacteria by repeating subculture with an agar medium several times from fruit bodies or sclerotia immediately after harvesting.

つぎにこのようなチヨレイマイタケ菌の種菌の培養には
禾本科(イネ科)植物培地を用いるとよい。ここで禾本
科植物とはイネ、ムギ、トウモロコシなどであり、これ
ら植物の培地とは細断された禾本科植物を主成分としこ
れに常水を加えただけのものであるが、必要に応じて禾
本科植物にコメぬか、麩などを混合したものにグルコー
ス、シヨ糖、麦芽エキス、バレイシヨエキス、酵母エキ
ス、ペプトンまたは無機塩類などを溶解させた水を加え
てもよい。そして培養に際しては、ガラス製、またはプ
ラスチツク製の容器に入れられた培地に種菌を接種し、
20〜30℃のもとで通常7〜15日間保持し充分に繁殖させ
る。培養を終われば、培養物をそのまままたは乾燥細粉
化して、たとえばステンレス製タンクなどの中で、水ま
たは3%以下の酸もしくはアルカリを含む水を用いて、
80〜100℃のもとに3〜6時間程度抽出する。抽出液は
遠心分離または濾過によつて精製され、得られた清澄液
を減圧濃縮した後、これに酢酸または三塩化酢酸を3〜
7%になるように添加して蛋白を除去し、透析を行な
う。さらにこの透析内液を減圧下(たとえば約700mm−H
g)に濃縮し、この濃縮液に80%以上になるように水に
可溶性の有機溶媒(たとえば、エチルアルコール、アセ
トンなど)を加えて生じる沈澱を集め、さらにこの沈澱
を90%以上の前記有機溶媒またはエーテル等で洗浄し、
乾燥すると抽出液の乾燥物が得られる。
Next, for culturing the inoculum of C. perfringens, it is advisable to use a plant medium of the family Gramineae (Poaceae). Here, the rice plants are rice, wheat, corn, etc., and the medium of these plants is the shredded plants as a main component and only normal water is added thereto, but if necessary, Water obtained by dissolving glucose, sucrose, malt extract, barley extract, yeast extract, peptone, or inorganic salts may be added to a mixture of rice bran, wheat bran, etc. And when culturing, inoculate the medium contained in a glass or plastic container with inoculum,
It is normally kept at 20 to 30 ° C for 7 to 15 days to allow it to reproduce sufficiently. When the culture is completed, the culture is used as it is or after it is pulverized to dry fine powder, for example, in a stainless steel tank or the like, using water or water containing 3% or less of acid or alkali,
Extract for 3 to 6 hours at 80 to 100 ° C. The extract is purified by centrifugation or filtration, and the obtained clear solution is concentrated under reduced pressure, and then acetic acid or trichloroacetic acid is added to
The protein is removed by adding 7% to dialysis. Furthermore, the dialysis solution is decompressed (for example, about 700 mm-H
g), concentrate the solution, add a water-soluble organic solvent (eg, ethyl alcohol, acetone, etc.) to the concentrated solution to 80% or more, collect the precipitate, and further collect this precipitate in 90% or more of the organic solvent. Wash with solvent or ether,
When dried, a dried product of the extract is obtained.

このようにして得られるチヨレイマイタケの菌糸体抽出
液もしくはその乾燥物を主成分として混入する皮膚外用
剤の形体は特に限定するものではないが、水溶液、乳液
(スキンミルク等)、クリーム、軟膏など塗布の容易な
ものが好都合である。そしてこれら皮膚外用剤に混入す
る菌糸体抽出液もしくはその乾燥物の量は乾燥物換算で
全量中0.05〜10.0%(%は重量%、以下同じ)を一つの
目安にすることが望ましい。なぜならば混入量が0.05%
未満の少量では期待される効果が得られず、また10.0%
を越える多量のときは着色、発臭等があつて好ましくな
いからである。
The form of the external preparation for skin in which the mycelium extract of Mytilus chinensis or the dried product thereof is mixed as the main component is not particularly limited, but an aqueous solution, an emulsion (skin milk, etc.), a cream, an ointment Those that are easy to apply are convenient. The amount of the mycelium extract or its dried product mixed in these external preparations for skin is preferably 0.05 to 10.0% (% is% by weight, the same applies hereinafter) of the total amount in terms of dried product. Because the amount mixed is 0.05%
If the amount is less than less than the expected effect, 10.0%
This is because when the amount exceeds a large amount, coloring and odor are generated, which is not preferable.

〔作用〕[Action]

この発明による皮膚外用剤は含有するチヨレイマイタケ
の抽出物の働きによつて皮膚賦活化およびチロジナーゼ
活性化などの作用を発現するのである。
The external preparation for skin according to the present invention exerts effects such as skin activation and tyrosinase activation by the action of the contained extract of Mytilus edulis.

〔実施例〕〔Example〕

秋田県北秋田郡の山林に自生しているチヨレイマイタケ
の子実体および菌核から寒天培地による数回の植継を経
て得られた雑菌の混入していない菌糸体を種菌とし、こ
の種菌を禾本科植物培地に接種し、27℃のもとに約10日
間培養した。得られた培養物に常水を加え、約90℃で約
4時間抽出し、抽出液を濾過し、濾液を減圧濃縮し、約
4%濃度になるよう酢酸を添加して除蛋白処理を行なつ
た。その後セロハン膜を用いて透析し、透析内液を減圧
濃縮し、これにエチルアルコールを加えて沈澱を生成さ
せ、この沈澱を集めてさらに95%エチルアルコールで洗
浄し、乾燥させて粉末状の抽出物を得た。
The mycelium free of miscellaneous bacteria obtained from several fruiting bodies and sclerotia of C. chinensis that grows naturally in the forests of Kita-Akita-gun, Akita Prefecture is used as an inoculum. The plant was inoculated into a rice plant medium and cultured at 27 ° C for about 10 days. Normal water is added to the obtained culture, extraction is performed at about 90 ° C for about 4 hours, the extract is filtered, the filtrate is concentrated under reduced pressure, and acetic acid is added to a concentration of about 4% for deproteinization. Natsuta. After that, it is dialyzed using a cellophane membrane, the dialyzed solution is concentrated under reduced pressure, ethyl alcohol is added to this to form a precipitate, and the precipitate is collected, washed with 95% ethyl alcohol, dried and extracted in powder form. I got a thing.

得られた抽出物の性状は第1表のとおりであつた。The properties of the obtained extract are shown in Table 1.

第1表 外観 淡灰色ないし淡褐色の非吸湿性粉末 性状 水に可溶、アルコール類、エーテル、クロロホ
ルム、ベンゼン等の有機溶媒に不溶 一定の融点を示さない pH(1%水溶液) 中性ないし微酸性 モーリツシユ反応 陽性 アンスロン硫酸反応 陽性 トリプトフアン硫酸反応 陽性 ビユレツト反応 陰性 キサントプロテイン反応 陰性 フエーリング氏反応 陰性 グルコース換算量(フエノール硫酸法) 40%以上 チロジナーゼ活性阻害率(%) −42.20 ここで、チロジナーゼ活性阻害率はつぎの方法で求め
た。すなわち、チロジナーゼはジヤガイモから得たもの
を精製したものの1mg/ml溶液2ml、L−チロジン0.05%
溶液1ml、リン酸緩衝液1/15ml(pH6.8)溶液2ml、Cu2+
イオン(1%CuSO4)溶液0.05mlおよび0.1%チヨレイマ
イタケ抽出物溶液2mlを加えて、その640μmの吸光度を
測定(その値をDとする)し、その後37℃で1時間保持
して、再度吸光度を測定(その値をD′とする)し、同
時に0.1%チヨレイマイタケ抽出物溶液の代わりに常水
を入れたものの吸光度を測定(それぞれの値をdおよび
d′とする)して、 から算出したものである。なお対照品としてチヨレイマ
イタケの代わりに1%ビタミンC水溶液を用いて同様の
測定を行ない、算出されたチロジナーゼ活性阻害率は8
6.24であつたので、0.1%チヨレイマイタケ抽出物水溶
液はメラニン生成を促進することが考えられる。
Table 1 Appearance Light gray to light brown non-hygroscopic powder Properties Soluble in water, insoluble in organic solvents such as alcohols, ethers, chloroform and benzene pH that does not show a certain melting point (1% aqueous solution) Neutral to slight Acid Mauritius reaction positive Anthuron sulfate reaction positive Tryptophan sulfate reaction positive Biuret reaction negative Xanthoprotein reaction negative Fehring's reaction negative glucose equivalent (phenol phenol method) 40% or more Tyrodinase activity inhibition rate (%) -42.20 Where, tyrodinase activity inhibition The rate was calculated by the following method. That is, the tyrosinase was obtained by purifying the product obtained from potato, 2 ml of 1 mg / ml solution, and 0.05% of L-tyrosine.
Solution 1 ml, phosphate buffer 1/15 ml (pH 6.8) solution 2 ml, Cu 2+
Ion (1% CuSO 4 ) solution (0.05 ml) and 0.1% T. chinensis extract solution (2 ml) were added, and the absorbance at 640 μm was measured (the value is D), and then the mixture was kept at 37 ° C. for 1 hour, Measure the absorbance again (the value is D '), and at the same time, measure the absorbance of the solution containing 0.1% T. chinensis extract solution with normal water (the respective values are d and d'). , It is calculated from. As a control product, a 1% aqueous solution of Vitamin C was used in place of Chlorella edulis, and the same measurement was performed.
Since it was 6.24, it is conceivable that the 0.1% aqueous solution of Lentinus edodes extract promotes melanin production.

実施例1および2: 第2表に示す配合割合でチヨレイマイタケ抽出物および
その他の成分を配合し、常温下で完全に溶解して化粧水
を得た。なお配合割合を示す%は重量%(以下同じ)で
ある。得られた化粧水に対して成人女子20人の官能試験
によつて荒れ肌、脂性肌の改善効果を「明らかに効果あ
り」(これを2点に採点)、「やや効果あり」(これを
1点に採点)、「効果なし」(これを0点に採点)の3
段階に評価し、全員の採点の合計点を求め、この合計点
の満点(40点)に対する百分率すなわち (合計点÷40)×100 を有効性(%)とし、算出された有効性(%)の値を
( )内に併記した。
Examples 1 and 2: Cholesterus edulis extract and other components were blended in the blending ratios shown in Table 2, and completely dissolved at room temperature to obtain a lotion. In addition,% showing the mixing ratio is weight% (hereinafter the same). According to the sensory test of 20 adult women with respect to the obtained lotion, the effect of improving rough skin and oily skin was "clearly effective" (scoring this to 2 points), "slightly effective" (1 degree to this) 3) of “No effect” (scoring this to 0)
Evaluated in stages and calculated the total score of all members. The percentage of the total score (40 points), that is, (total score ÷ 40) x 100 is the efficacy (%), and the calculated efficacy (%) The value of is also shown in parentheses.

比較例 チヨレイマイタケ抽出物を用いなかつたこと以外は実施
例1と全く同様の操作を行なつて化粧水を調製した。得
られた化粧水に対する官能試験の評価結果を第2表に併
記したが、実施例1および2のいずれよりも遥かに劣つ
たものであつた。
Comparative Example A lotion was prepared in the same manner as in Example 1 except that the extract of Agarnetus chinensis was not used. The evaluation results of the sensory test on the obtained lotion are also shown in Table 2, which is far inferior to both Examples 1 and 2.

実施例3: 第1相として、 % ミリスチン酸オクチルドデシル 5.0 スクワラン 10.0 ステアリン酸 10.0 ホホバ油 3.0 天然ビタミンE 0.1 モノオレイン酸ポリオキシエチレンソルビタン(20E.
O.) 1.0 第2相として チヨレイマイタケ抽出物 3.0 キサンタンガム 0.1 L−アルギニン 1.0 濃グリセリン 3.0 1,3−ブチレングリコール 5.0 精製水 58.8 をそれぞれ準備し、まず第1相を80℃で溶解し、これに
同温度で加熱溶解した第2相の溶液を加え、ホモジナイ
ザーで充分混合した後、35℃まで冷却してスキンクリー
ムを得た。このスキンクリームについて実施例1におけ
ると同様の官能試験を実施したところ、得られた評価結
果は実施例1および2と同様の優れたものであつた。
Example 3: As the first phase,% octyldodecyl myristate 5.0 squalane 10.0 stearic acid 10.0 jojoba oil 3.0 natural vitamin E 0.1 polyoxyethylene sorbitan monooleate (20E.
O.) 1.0 Chlorella maitake extract 3.0 Xanthan gum 0.1 L-arginine 1.0 Concentrated glycerin 3.0 1,3-butylene glycol 5.0 Purified water 58.8 are prepared as the second phase. First, the first phase is dissolved at 80 ° C. The solution of the second phase, which was heated and dissolved at the same temperature, was added to the mixture, thoroughly mixed with a homogenizer, and then cooled to 35 ° C. to obtain a skin cream. When this skin cream was subjected to the same sensory test as in Example 1, the obtained evaluation results were the same as those in Examples 1 and 2.

実施例4: 第1相として、 % 白色ワセリン 25 ステアリルアルコール 22 プロピレングリコール 12 ラウリル硫酸ナトリウム 1.5 パラオキシ安息香酸エチル 0.025 パラオキシ安息香酸プロピル 0.015 第2相として チヨレイマイタケ抽出物 5 精製水 残り全部 をそれぞれ準備しておき、まず十改正日本薬局方親水軟
膏の製法に準じて第1相の成分を加熱溶解して75℃の混
合物を調製し、これに75℃で加熱溶解した第2相の溶液
を加えて攪拌しながら冷却して親水軟膏を得た。この軟
膏を荒れ肌および湿しんの人に適用したところ、優れた
効果のあることがわかつた。また、この発明の軟膏に、
通常の化粧品、医薬部外品、医薬品に添加される防腐殺
菌剤、紫外線吸収剤、ビタミン剤、その他を配合しても
何らの支障も生じなかつた。
Example 4: As the first phase,% white petrolatum 25 Stearyl alcohol 22 Propylene glycol 12 Sodium lauryl sulfate 1.5 Ethyl paraoxybenzoate 0.025 Propyl paraoxybenzoate 0.015 As the second phase, Chlorella edulis extract 5 Purified water All the rest are prepared respectively First, according to the 10th revised Japanese Pharmacopoeia hydrophilic ointment manufacturing method, the ingredients of the first phase are heated and dissolved to prepare a mixture at 75 ° C, and the solution of the second phase heated and dissolved at 75 ° C is added to this. The mixture was cooled with stirring to obtain a hydrophilic ointment. When this ointment was applied to people with rough skin and eczema, it was found to have excellent effects. In addition, the ointment of the present invention,
No problem occurred even if ordinary cosmetics, quasi-drugs, antiseptic germicides added to medicines, ultraviolet absorbers, vitamins, etc. were added.

〔効果〕〔effect〕

以上述べたように、この発明の皮膚外用剤はチヨレイマ
イタケ抽出物における皮膚賦活効果により、脂性肌、荒
れ肌を正常化すると共に、湿しん等にも優れた効果を現
わし、さらにメラニンの生成を促すので色白の人に対し
ては適度の健康色の発現を期待することが出来るので、
この発明の意義はきわめて大きいといえる。
As described above, the external preparation for skin of the present invention has a skin activating effect in the extract of Mytilus edulis, which normalizes oily skin and rough skin, and also exhibits excellent effects on eczema and the like, and further produces melanin. Since it encourages, it can be expected that a moderately healthy color will appear for people with fair skin,
The significance of this invention can be said to be extremely great.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 柴山 裕治 大阪府大阪市東区道修町2丁目51番地 岩 瀬コスフア株式会社内 (72)発明者 川田 勝作 栃木県足利市毛野新町2―90 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yuji Shibayama 2-51, Doshomachi, Higashi-ku, Osaka, Osaka Iwase Coshua Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】サルノコシカケ科チヨレイマイタケ〔Poly
porusumbellatus Fries(Polyporaceae)〕の子実体ま
たは新鮮な菌核から分離培養した菌糸体抽出液もしくは
その乾燥物を含有することを特徴とする皮膚外用剤。
1. A Polygonaceae, Polygonaceae
porusumbellatus Fries (Polyporaceae)] a fruit body or a mycelium extract separated and cultured from fresh sclerotium or a dried product thereof, which is an external preparation for skin.
JP61152362A 1986-06-27 1986-06-27 External skin preparation Expired - Fee Related JPH075472B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61152362A JPH075472B2 (en) 1986-06-27 1986-06-27 External skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61152362A JPH075472B2 (en) 1986-06-27 1986-06-27 External skin preparation

Publications (2)

Publication Number Publication Date
JPS638336A JPS638336A (en) 1988-01-14
JPH075472B2 true JPH075472B2 (en) 1995-01-25

Family

ID=15538875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61152362A Expired - Fee Related JPH075472B2 (en) 1986-06-27 1986-06-27 External skin preparation

Country Status (1)

Country Link
JP (1) JPH075472B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005096456A1 (en) * 2004-03-31 2005-10-13 Matsushita Electric Works, Ltd. Connector

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2753936B2 (en) * 1993-04-30 1998-05-20 株式会社雪国まいたけ Method for producing type I and type II diabetes ameliorator
JP2698956B2 (en) * 1993-04-30 1998-01-19 株式会社雪国まいたけ Method for producing wound treatment agent
JP2001163754A (en) * 1999-12-06 2001-06-19 Nippon Zettoc Co Ltd Anti-aging agent and cosmetic formulated therewith
JP2004189737A (en) * 2002-11-28 2004-07-08 Keiichiro Hiyama Antifungal agent
CN1332019C (en) * 2004-05-26 2007-08-15 张鑫 Grifola umbellate zymophyte powder and grifola umbellate polysaccharide producing method and products therefrom

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005096456A1 (en) * 2004-03-31 2005-10-13 Matsushita Electric Works, Ltd. Connector

Also Published As

Publication number Publication date
JPS638336A (en) 1988-01-14

Similar Documents

Publication Publication Date Title
US7678368B2 (en) Fucoidan-containing cosmetics
JPH0648934A (en) Skin external agent
JP2003081863A (en) Mycelium bioactive substance of Kusunoki mushroom, its composition, and method for producing the same
JPH075472B2 (en) External skin preparation
KR101515073B1 (en) Trisin inclusion complex, a preparation method thereof, and a cosmetic composition for anti-oxidant and anti-inflammatory comprising the same
JP2003104865A (en) External preparation for skin
JP3934017B2 (en) Cosmetics
JP2004315512A (en) Functional composition
JP4451100B2 (en) Immunostimulant and anticancer agent containing Tamogitake fruit body composition as active ingredient
KR20200059446A (en) Cosmetic composition comprising the extract of fermented Sprout leaf/stem ginseng for skin anti-wrinkle effect and producing method thereof
US7060470B2 (en) Isoflavone-β-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same
JPH09143024A (en) External preparation composition
JP2004189737A (en) Antifungal agent
KR20040105601A (en) Cosmetic material
KR102154140B1 (en) Composition comprising tulip leaf extract, amorphophallus paeoniifolius hydrolysis extract and parrot ferment extract
JP2002104952A (en) External preparation for skin
JP2005281224A (en) Skin-whitening agent
KR101877484B1 (en) A Composition Comprising Steviol Glucopyranosyl Ester Having Anti-Inflammation Activity and Preparation Method Thereof
KR20170005534A (en) The Cosmetic composition containing the culture medium of mycelium from Elfvingia applanata using natural medium
KR100320743B1 (en) Extracts of Phellinus linteus having anti-oxidizing, whitening, moisturizing, immunoenhancing and anti-acne activities, preparation method and use thereof
JP2745056B2 (en) Cosmetics
KR101888999B1 (en) Cosmetic composition containing ultrasonicating extract of mahkota dewa
KR102891020B1 (en) Cosmetic composition for skin care comprising acorn fermented produce fermented with Saccharomyces cerevisiae or Aspergillus oryzae as an active ingredient
KR20150017206A (en) Fermentation metabolite of Dendropanax morbiferus produced by solid-state fermentation and manufacturaring process for the same
JPWO2006126488A1 (en) Hanabira bamboo extract

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees